ENDPOINTS

Exclusive: AI biotech Atomwise hires new CEO, raises $45M Series C

Atomwise spent most of its first 12 years talking up the potential of AI in making molecules. Now, the biotech startup is turning to an industry veteran with over 35 years of biotech experience to ...

Feb 18, 2025 - 13:03
 0
Exclusive: AI biotech Atomwise hires new CEO, raises $45M Series C
Atomwise spent most of its first 12 years talking up the potential of AI in making molecules. Now, the biotech startup is turning to an industry veteran with over 35 years of biotech experience to ...
Read More

Tags:

Previous Article

Exclusive: Lithuanian biotech Atrandi Biosciences raises $25M Series A

Next Article

‘Max Mustard’ Studio Lays Off Majority of Staff & Closes Office, Vows to Continu...

Related Posts

States sue Trump administration over billions in NIH indirect cost cuts

States sue Trump administration over billions in NIH in...

Feb 10, 2025  0

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Roivant discontinues lung disease drug; Bio-Thera, Inta...

Feb 10, 2025  0

Inside the Accolade-Transcarent deal

Inside the Accolade-Transcarent deal

Feb 20, 2025  0